NIMH's TADS

More than just a tad of progress?

Peter S. Jensen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The Treatment for Adolescents With Depression Study (TADS) derives substantial public health significance from its head-to-head comparisons of carefully administered medication versus a carefully crafled cognitive-behavioral therapy in youth with major depression, the first major clinical trial of its kind. Although the study has a number of limitations, to include somewhat higher than expected socioeconomic status of participants and a somewhat lower than expected rate of minority participation, it stands as an investigation of major international significance in our understanding of effective treatments for adolescents with major depressive disorder. Further studies will need to ensure that its findings are broadly generalizable across the U.S. population, and to parse out the active ingredients of psychotherapies and determine how those active ingredients are related to changes in psychological mechanisms related to depressive disorders.

Original languageEnglish (US)
Pages (from-to)156-158
Number of pages3
JournalCognitive and Behavioral Practice
Volume12
Issue number2
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

National Institute of Mental Health (U.S.)
Depression
Major Depressive Disorder
Cognitive Therapy
Depressive Disorder
Social Class
Psychotherapy
Therapeutics
Public Health
Clinical Trials
Psychology
Population

ASJC Scopus subject areas

  • Psychology(all)
  • Clinical Psychology

Cite this

NIMH's TADS : More than just a tad of progress? / Jensen, Peter S.

In: Cognitive and Behavioral Practice, Vol. 12, No. 2, 2005, p. 156-158.

Research output: Contribution to journalArticle

Jensen, Peter S. / NIMH's TADS : More than just a tad of progress?. In: Cognitive and Behavioral Practice. 2005 ; Vol. 12, No. 2. pp. 156-158.
@article{80e7f8ac00d940c6b53536323d4be2b8,
title = "NIMH's TADS: More than just a tad of progress?",
abstract = "The Treatment for Adolescents With Depression Study (TADS) derives substantial public health significance from its head-to-head comparisons of carefully administered medication versus a carefully crafled cognitive-behavioral therapy in youth with major depression, the first major clinical trial of its kind. Although the study has a number of limitations, to include somewhat higher than expected socioeconomic status of participants and a somewhat lower than expected rate of minority participation, it stands as an investigation of major international significance in our understanding of effective treatments for adolescents with major depressive disorder. Further studies will need to ensure that its findings are broadly generalizable across the U.S. population, and to parse out the active ingredients of psychotherapies and determine how those active ingredients are related to changes in psychological mechanisms related to depressive disorders.",
author = "Jensen, {Peter S.}",
year = "2005",
doi = "10.1016/S1077-7229(05)80020-3",
language = "English (US)",
volume = "12",
pages = "156--158",
journal = "Cognitive and Behavioral Practice",
issn = "1077-7229",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - NIMH's TADS

T2 - More than just a tad of progress?

AU - Jensen, Peter S.

PY - 2005

Y1 - 2005

N2 - The Treatment for Adolescents With Depression Study (TADS) derives substantial public health significance from its head-to-head comparisons of carefully administered medication versus a carefully crafled cognitive-behavioral therapy in youth with major depression, the first major clinical trial of its kind. Although the study has a number of limitations, to include somewhat higher than expected socioeconomic status of participants and a somewhat lower than expected rate of minority participation, it stands as an investigation of major international significance in our understanding of effective treatments for adolescents with major depressive disorder. Further studies will need to ensure that its findings are broadly generalizable across the U.S. population, and to parse out the active ingredients of psychotherapies and determine how those active ingredients are related to changes in psychological mechanisms related to depressive disorders.

AB - The Treatment for Adolescents With Depression Study (TADS) derives substantial public health significance from its head-to-head comparisons of carefully administered medication versus a carefully crafled cognitive-behavioral therapy in youth with major depression, the first major clinical trial of its kind. Although the study has a number of limitations, to include somewhat higher than expected socioeconomic status of participants and a somewhat lower than expected rate of minority participation, it stands as an investigation of major international significance in our understanding of effective treatments for adolescents with major depressive disorder. Further studies will need to ensure that its findings are broadly generalizable across the U.S. population, and to parse out the active ingredients of psychotherapies and determine how those active ingredients are related to changes in psychological mechanisms related to depressive disorders.

UR - http://www.scopus.com/inward/record.url?scp=32444444642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32444444642&partnerID=8YFLogxK

U2 - 10.1016/S1077-7229(05)80020-3

DO - 10.1016/S1077-7229(05)80020-3

M3 - Article

VL - 12

SP - 156

EP - 158

JO - Cognitive and Behavioral Practice

JF - Cognitive and Behavioral Practice

SN - 1077-7229

IS - 2

ER -